On Monday, in the course of current trade, Shares of Citigroup Inc. (NYSE:C), gained 1.16%, and is now trading at $54.71.
Citigroup, will issue its second quarter results via press release at about 8:00 AM (ET) on Thursday, July 16, 2015. At 11:00 AM (ET), results will be reviewed via live webcast and teleconference.
To dial-in to the live teleconference, please call (866) 516-9582 (for U.S. and Canada callers) or (973) 409-9210 (for international callers). Conference ID: 57649611. A telephonic replay of the call will be accessible starting about two hours after the event until Thursday, July 23, 2015 by calling (855) 859-2056 (for U.S. and Canada callers) or (404) 537-3406 (for international callers). Conference ID: 57649611.
Citigroup Inc., a diversified financial services holding company, provides various financial products and services for consumers, corporations, governments, and institutions worldwide. The company operates through two segments, Global Consumer Banking (GCB) and Institutional Clients Group (ICG).
During an Afternoon trade, Shares of United Rentals, Inc. (NYSE:URI), gained 1.74%, and is now trading at $90.46.
United Rentals, declared the further expansion of its specialty branch network with the addition of eight U.S. locations and two in Canada:
- The United Rentals Pump Solutions branches in Atlanta, Ga., Carlsbad, N.M., Elmwood Park, N.J., Hayward, Calif., Saskatoon, Sask., and Prince George, B.C., will provide fluid transfer solutions for industrial and commercial applications ranging from high volume and high pressure pumps to small, portable units, counting custom fabrication.
- The United Rentals Tool Solutions branches in Charlotte, N.C., and Ridgefield Park, N.J., will provide temporary and long-term onsite tool administration, counting inventory tracking, inspections and maintenance.
- The United Rentals Power & HVAC branch in Amarillo, Texas, will provide engineered power, heating, cooling and ventilation solutions for commercial, industrial and governmental customers, and disaster recovery services.
- The United Rentals Trench Safety branch in Lake Charles, La., will provide engineered excavation support and confined space entry systems, in addition to worker training.
United Rentals, Inc., through its auxiliaries, operates as an equipment rental company. It operates in two segments, General Rentals; and Trench Safety, Power and HVAC (heating, ventilating and air conditioning), and Pump Solutions.
Shares of Delcath Systems, Inc. (NASDAQ:DCTH), during its Monday’s current trading session fell -2.08%, and is now trading at $1.41.
Delcath Systems, declared that results of a large, European single-center experience of the treatment of uveal melanoma patients with hepatic metastases with the Delcath Hepatic CHEMOSAT® Delivery System, were highlighted in an on-line abstract at the American Society of Clinical Oncology Annual Meeting 2015.
Uveal melanoma (UM), also known as ocular melanoma, is a rare cancer of the eye with a very poor prognosis. According to the study authors, “50% of patients develop distant disease, mainly in the liver (90%), with a mean survival of 6 months and 1-year survival rate of 15-20%.”
In this study, 20 patients received 34 treatments with CHEMOSAT (1-3 treatments per patient). Radiologically, 2 patients (10%) demonstrated stable disease for >3 months, 13 patients (65%) had a partial response in the liver with complete responses in 2 patients (10%). Nine deaths from disease progression occurred after a median of 264 days from the first procedure. Eleven patients remain alive after a median of 280 days with one complete response ongoing at >1 year. From the diagnosis of liver metastases, 11 patients (55%) have survived to one year and 3 (15%) for >2 years. No procedure related deaths were seen.
Adverse events (AEs) seen were grade 1 (n=12), 2 (n=13), 3 (n=5) and 4 (n=1). The grade 4 complication was pulmonary edema due to fluid overload. Early AEs often predictable with percutaneous hepatic perfusion (PHP) were observed counting coagulopathy, electrolyte disturbances and transient transaminases (elevated liver enzymes). Rare late AEs (1 patient each) comprised of hair loss, skin rash, myelosuppression and persistent transaminases (elevated liver enzymes).
Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Delivery System; and markets melphalan hydrochloride as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan in Europe.
Finally, AbbVie Inc. (NYSE:ABBV), gained 0.77% Monday.
AbbVie, will take part in the Jefferies 2015 Healthcare Conference on Thursday, June 4, 2015. Richard A. Gonzalez, chairman and chief executive officer, will take part in a question and answer session at 8:30 a.m. Central time.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products comprise HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-oral, short-course, interferon-free therapy, with or without ribavirin, for adult patients with genotype 1 chronic hepatitis, counting those with compensated cirrhosis.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
